About Supplant
Supplant is a company based in Cambridge (United Kingdom) founded in 2017 by Tom Simmons. Supplant has raised $25 million across 1 funding round from investors including Khosla Ventures, EQT and Felicis Ventures. Supplant offers products and services including Sustainable Ingredients.
- Headquarter Cambridge, United Kingdom
- Founders Tom Simmons
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25 M (USD)
in 1 rounds
-
Latest Funding Round
$25 M (USD), Series A
Mar 15, 2021
-
Investors
Khosla Ventures
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Supplant
Supplant offers a comprehensive portfolio of products and services, including Sustainable Ingredients.
Replacements for refined sugar and starch from agricultural waste.
People of Supplant
Unlock access to complete
Unlock access to complete
Funding Insights of Supplant
Supplant has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Supplant
Supplant has secured backing from 9 investors, including venture fund and angel investors. Prominent investors backing the company include Khosla Ventures, EQT and Felicis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investments in technology startups are made by Felicis Ventures.
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked |
Investor details for Supplant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Supplant
Investment portfolio details for Supplant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Supplant
Detailed financials for Supplant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Supplant Comparisons
Peer comparison for Supplant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Supplant
Detailed competitors of Supplant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Supplant
Complete news archive for Supplant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supplant
Supplant was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Supplant is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Tom Simmons is the current CEO of Supplant. They have also founded this company.
Supplant is a funded company, having raised a total of $25M across 1 funding round to date.
Supplant was founded in 2017 in Cambridge, United Kingdom, as an internet-first brand focused on chocolate products. Operations center on online sales and distribution of chocolate items, with Tom Simmons serving as founder and CEO. The company operates within the consumer goods sector, emphasizing direct-to-consumer e-commerce models. No physical retail presence is indicated beyond the digital platform.
Supplant offers Sustainable Ingredients.
Supplant has 9 investors. Key investors include Khosla Ventures, EQT, Felicis Ventures, Coatue, and Y Combinator.